Mental healthtech company NeuroFlow raised a $25M growth round
Plans for the round include investing in R&D for its tech platform and hiring across all teams. The news follows the company’s recent move to a new Center City office.
Excerpt from the Press Release:
Following a $20 million Series B round last year, NeuroFlow just closed a $25 million round of financing to continue its growth, the mental healthtech company announced Thursday.
The company makes a platform that facilitates mental healthcare management for patients in between traditional office visits. Last year, NeuroFlow scaled its operations in data analytics, artificial intelligence and direct health record integrations. Its flagship software allows clinicians to see data from wearable devices, assign tasks such as meditation or journaling for patients to complete at home, and send automated motivational emails.
The $25 million round was led by SEMCAP Health, which NeuroFlow called a “new strategic partner.” With the funding, NeuroFlow will keep expanding its referral network, deepen relationships with payers and providers to “identify and triage individuals with behavioral health needs across the spectrum of care.” The company will also invest in further R&D for its tech platform, and increase headcount across all departments to “support rapid growth.”
Click the button below to read the entire Press Release:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?